European Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European Ledger.

Press releases published on October 26, 2026

Oct. 26, 2026

Interact brings 700 intranet capabilities to enterprise AI assistants with Interact MCP

Indeterminate GlobeNewswire

Oct. 26, 2026

CasZyme and Cirena to Collaborate on Developing Longer Guide RNAs to Optimise Cas12l Performance

Indeterminate GlobeNewswire

Oct. 26, 2026

Purple connects Kinetic's Melbourne Airport bus fleet

Indeterminate GlobeNewswire

Oct. 26, 2026

Elevra Lithium Completes Sale of Ewoyaa Project Interest

Indeterminate GlobeNewswire

Oct. 26, 2026

RedCloud Repays All Convertible Notes In Full

Indeterminate GlobeNewswire

Oct. 26, 2026

NeOnc Targets Major Brain Cancer Trial Expansion with 500 Patients Across 30 Hospitals in Three Countries

Indeterminate GlobeNewswire

Oct. 26, 2026

Niki BioSolutions Announces New York State Approval for Its APOE Genotyping Test Using Dried Blood Spots, Plasma, and Urine

Indeterminate GlobeNewswire

Oct. 26, 2026

Oil Tops $116 as Britain's Small Businesses Face a Fight for Survival

Indeterminate EIN Presswire

Oct. 26, 2026

STMicroelectronics announces status of common share repurchase program

Indeterminate GlobeNewswire

Oct. 26, 2026

ASML reports transactions under its current share buyback program

Indeterminate GlobeNewswire

Oct. 26, 2026

Avacta Group plc: Faridoxorubicin Treatment Results in Near Doubling of Progression-Free Survival and Clinically Meaningful Tumor Shrinkage in Most Patients with Salivary Gland Cancers

Indeterminate GlobeNewswire

Oct. 26, 2026

Namib Minerals Announces Expanded Milling Plant at How Mine Operating at Full Capacity, Ahead of Schedule

Indeterminate GlobeNewswire

Oct. 26, 2026

CryptoHoldings Opens CHT Public Offer on Base, Launches DAO Voting for First Planned Property

Indeterminate GlobeNewswire

Oct. 26, 2026

Medicenna Reports Potent CD122 Blockade and Extended Survival with MDNA209 in Preclinical Models of Autoimmune Disease

Indeterminate GlobeNewswire

Oct. 26, 2026

Ambros Therapeutics Announces Planned Interim Analysis of Phase 3 Clinical Trial Following FDA Feedback

Indeterminate GlobeNewswire

Oct. 26, 2026

Allogene Therapeutics Announces Participation in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Oct. 26, 2026

Critical Metals Corp. Acquisition of European Lithium Approved by Supreme Court of Western Australia

Indeterminate GlobeNewswire

Oct. 26, 2026

Interact brings 700 intranet capabilities to enterprise AI assistants with Interact MCP

Indeterminate GlobeNewswire

Oct. 26, 2026

MarketFully Partners With Cyprus Airways to Personalize the Experience for International Travelers

Indeterminate EIN Presswire

Oct. 26, 2026

WISeSat.Space Announces SEALSQ’s Firm Intent to Acquire Capacity and Operational Services Associated with 12 Satellites for QSOC

Indeterminate GlobeNewswire